BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 21902653)

  • 1. Inhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignancies.
    Smolewski P; Robak T
    Curr Mol Med; 2011 Nov; 11(8):633-49. PubMed ID: 21902653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of apoptotic proteins: new targets for anticancer therapy.
    Saleem M; Qadir MI; Perveen N; Ahmad B; Saleem U; Irshad T; Ahmad B
    Chem Biol Drug Des; 2013 Sep; 82(3):243-51. PubMed ID: 23790005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of the inhibitor of apoptosis protein (IAP) family in hematological malignancies].
    Grzybowska-Izydorczyk O; Smolewski P
    Postepy Hig Med Dosw (Online); 2008 Feb; 62():55-63. PubMed ID: 18283236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the inhibitor of Apoptosis Protein BIR3 binding domains.
    Jaquith JB
    Pharm Pat Anal; 2014 May; 3(3):297-312. PubMed ID: 24998289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex.
    Arora V; Cheung HH; Plenchette S; Micali OC; Liston P; Korneluk RG
    J Biol Chem; 2007 Sep; 282(36):26202-9. PubMed ID: 17613533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting inhibitor of apoptosis proteins (IAPs) with IAP inhibitors sensitises malignant rhabdoid tumour cells to cisplatin.
    Coyle R; O'Sullivan MJ; Zisterer DM
    Cancer Treat Res Commun; 2022; 32():100579. PubMed ID: 35613525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Potent SMAC Mimetics that Sensitize Cancer Cells to TNF Family-Induced Apoptosis.
    Welsh K; Milutinovic S; Ardecky RJ; Gonzalez-Lopez M; Ganji SR; Teriete P; Finlay D; Riedl S; Matsuzawa S; Pinilla C; Houghten R; Vuori K; Reed JC; Cosford ND
    PLoS One; 2016; 11(9):e0161952. PubMed ID: 27617834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitor of apoptosis proteins in hematological malignancies.
    Fulda S
    Leukemia; 2009 Mar; 23(3):467-76. PubMed ID: 19039324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma.
    Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Edenfield HR; Glickman JN; Yeap BY; Sugarbaker DJ; Bueno R
    J Pathol; 2007 Mar; 211(4):447-54. PubMed ID: 17253596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and prognostic significance of the inhibitor of apoptosis protein (IAP) family and its antagonists in chronic lymphocytic leukaemia.
    Grzybowska-Izydorczyk O; Cebula B; Robak T; Smolewski P
    Eur J Cancer; 2010 Mar; 46(4):800-10. PubMed ID: 20045309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs.
    Zobel K; Wang L; Varfolomeev E; Franklin MC; Elliott LO; Wallweber HJ; Okawa DC; Flygare JA; Vucic D; Fairbrother WJ; Deshayes K
    ACS Chem Biol; 2006 Sep; 1(8):525-33. PubMed ID: 17168540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of inhibitor of apoptosis proteins in B-cell non-Hodgkin and Hodgkin lymphomas.
    Akyurek N; Ren Y; Rassidakis GZ; Schlette EJ; Medeiros LJ
    Cancer; 2006 Oct; 107(8):1844-51. PubMed ID: 16983704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Pan-Cancer Analysis of the BIRC Gene Family and Its Association with Prognosis, Tumor Microenvironment, and Therapeutic Targets.
    Wu S; Zang Q; Xing Z; Li X; Leng J; Liu Y; Wang X; Yang J
    Crit Rev Eukaryot Gene Expr; 2021; 31(4):35-48. PubMed ID: 34587434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The RING domain of cIAP1 mediates the degradation of RING-bearing inhibitor of apoptosis proteins by distinct pathways.
    Cheung HH; Plenchette S; Kern CJ; Mahoney DJ; Korneluk RG
    Mol Biol Cell; 2008 Jul; 19(7):2729-40. PubMed ID: 18434593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoprotective effects of IAPs revealed by a small molecule antagonist.
    Galbán S; Hwang C; Rumble JM; Oetjen KA; Wright CW; Boudreault A; Durkin J; Gillard JW; Jaquith JB; Morris SJ; Duckett CS
    Biochem J; 2009 Feb; 417(3):765-71. PubMed ID: 18851715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different Degradation Mechanisms of Inhibitor of Apoptosis Proteins (IAPs) by the Specific and Nongenetic IAP-Dependent Protein Eraser (SNIPER).
    Ohoka N; Ujikawa O; Shimokawa K; Sameshima T; Shibata N; Hattori T; Nara H; Cho N; Naito M
    Chem Pharm Bull (Tokyo); 2019 Mar; 67(3):203-209. PubMed ID: 30369550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibitor of apoptosis protein family and its antagonists in acute leukemias.
    Wrzesień-Kuś A; Smolewski P; Sobczak-Pluta A; Wierzbowska A; Robak T
    Apoptosis; 2004 Nov; 9(6):705-15. PubMed ID: 15505413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploiting inhibitor of apoptosis proteins as therapeutic targets in hematological malignancies.
    Fulda S
    Leukemia; 2012 Jun; 26(6):1155-65. PubMed ID: 22230799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The BIRC6 gene as a novel target for therapy of prostate cancer: dual targeting of inhibitors of apoptosis.
    Luk SU; Xue H; Cheng H; Lin D; Gout PW; Fazli L; Collins CC; Gleave ME; Wang Y
    Oncotarget; 2014 Aug; 5(16):6896-908. PubMed ID: 25071009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel small-molecule IAP antagonist, AZD5582, draws Mcl-1 down-regulation for induction of apoptosis through targeting of cIAP1 and XIAP in human pancreatic cancer.
    Moon JH; Shin JS; Hong SW; Jung SA; Hwang IY; Kim JH; Choi EK; Ha SH; Kim JS; Kim KM; Hong DW; Kim D; Kim YS; Kim JE; Kim KP; Hong YS; Choi EK; Lee JS; Hattersley M; Jin DH; Kim TW
    Oncotarget; 2015 Sep; 6(29):26895-908. PubMed ID: 26314849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.